Immediate Impact
4 from Science/Nature 62 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Anke Mayer‐Bartschmid being referenced
Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody–Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Anke Mayer‐Bartschmid | 143 | 148 | 135 | 10 | 488 | |
| W. A. Dengler | 60 | 250 | 172 | 10 | 526 | |
| Shannon L. Ward | 174 | 286 | 55 | 16 | 497 | |
| Gary A. Howie | 55 | 179 | 124 | 9 | 438 | |
| R Bai | 160 | 242 | 160 | 8 | 510 | |
| Hana Anderson | 48 | 315 | 151 | 16 | 512 | |
| AT McGown | 55 | 235 | 138 | 11 | 489 | |
| Kuei-Li Lin | 63 | 285 | 116 | 13 | 498 | |
| Andrew M. Hau | 121 | 294 | 56 | 22 | 538 | |
| Michael Wheatcroft | 269 | 312 | 58 | 16 | 488 | |
| Kathryn M. Marshall | 92 | 284 | 40 | 17 | 552 |
All Works
Loading papers...